Burden of congenital rubella syndrome (CRS) in India: A systematic review

Indian Pediatrics

Volumn 49, Issue 5, 2012, Pages 377-399

  Dewan, Pooja ^a   Gupta, Piyush ^a,b  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b Dilshad Garden   (India)

Author keywords

Congenital rubella syndrome; India; Prevalence; Rubella; Susceptibility; Vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AGE DISTRIBUTION; CATARACT; CLINICAL EVALUATION; CLINICAL FEATURE; CONGENITAL RUBELLA SYNDROME; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; EYE MALFORMATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HEARING IMPAIRMENT; HIGH RISK PREGNANCY; HUMAN; IMMUNOGENICITY; INDIA; INFECTION RISK; INTRAUTERINE INFECTION; MENTAL DEFICIENCY; PATIENT ASSESSMENT; PREVALENCE; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RUBELLA SYNDROME, CONGENITAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 84866026689     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-012-0087-4     Document Type: Review

References (88)

1. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: Global update. Rev Panam Salud Publica. 2003;14:306-15.
2. Centers for Disease Control and Prevention (CDC). Progress toward control of rubella and prevention of congenital rubella syndrome-worldwide, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1307-10.
3. Preblud SR, Serdula MK, Frank JA Jr, Brandling-Bennett AD, Hinman AR. Rubella vaccination in the United States: A ten-year review. Epidemiol Rev.1980;2:171-94.
4. Dudgeon JA. Selective immunization: Protection of the individual. Rev Infect Dis. 1985;7 Suppl 1:S185-90.
5. WHO Publication. Rubella vaccines: WHO position paperrecommendations. Vaccine. 2011;29:8767-8.
6. Castillo-Solórzano C, Marsigli C, Bravo-Alcántara P, Flannery B, Ruiz Matus C, Tambini G, et al. Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis. 2011;204 Suppl 2:S571-8.
7. Lambert SR. Congenital rubella syndrome: The end is in sight. Br J Ophthalmol. 2007;91:1418-9.
8. Mathew JL, Shah D, Gera T, Gogia S, Mohan P, Panda R, Menon S, Gupta P. UNICEF-PHFI Series on newborn and child health, India: methodology for systematic reviews on child health priorities for advocacy and action. Indian Pediatr. 2011;48:183-9.
9. Council for State and Territorial Epidemiologists. Rubella Syndrome, Congenital. Case definition 2010. Available from: http://www.cdc.gov/osels/ph- surveillance/nndss/casedef/rubellasc-current.htm. Accessed on February 13, 2012.
10. Das S, Ramachandran VG, Arora R. Cytomegalovirus and rubella infection in children and pregnant mothers-A hospital based study. J Commun Dis. 2007;39:113-7.
11. Chakravarti A, Jain M. Rubella prevalence and its transmission in children. Indian J Pathol Microbiol. 2006;49:54-6.
12. Deorari AK, Broor S, Maitreyi RS, Agarwal D, Kumar H, Paul VK, Singh M. Incidence, clinical spectrum, and outcome of intrauterine infections in neonates. J Trop Pediatr. 2000;46:155-9.
13. Abraham M, Abraham P, Jana AK, Kuruvilla KA, Cherian T, Moses PD, et al. Serology in congenital infections: Experience in selected symptomatic infants. Indian Pediatr. 1999; 36:697-700.
14. Ballal M, Shivananda PG. Prevalence of rubella virus in suspected cases of congenital infections. Indian J Pediatr. 1997;64:231-5.
15. Broor S, Kapil A, Kishore J, Seth P. Prevalence of rubella virus and cytomegalovirus infections in suspected cases of congenital infections. Indian J Pediatr. 1991;58:75-8.
16. Manjunath N, Balaya S. Serological study on congenital rubella in Delhi. Indian J Med Res. 1984;79:716-21.
17. Singh MP, Arora S, Das A, Mishra B, Ratho RK. Congenital rubella and cytomegalovirus infections in and around Chandigarh. Indian J Pathol Microbiol. 2009;52:46-8.
18. Chandy S, Abraham AM, Jana AK, Agarwal I, Kekre A, Korula G, et al. Congenital rubella syndrome and rubella in Vellore, South India. Epidemiol Infect. 2011;139:962-6.
19. Rajasundari TA, Sundaresan P, Vijayalakshmi P, Brown DW, Jin L. Laboratory confirmation of congenital rubella syndrome in infants: An eye hospital based investigation. J Med Virol. 2008;80:536-46.
20. Chakrabarty MS, Das BC, Gupta B, Sarkar JK. Rubella as an aetiological factor of congenital malformation in Calcutta-A serological study. Indian J Med Res.1975;63:1438-45.
21. Vijayalakshmi P, Rajasundari TA, Prasad NM, Prakash SK, Narendran K, Ravindran M, et al. Prevalence of eye signs in congenital rubella syndrome in South India: A role for population screening. Br J Ophthalmol. 2007;91:1467-70.
22. Chaturvedi UC, Tripathi BN, Mathur A, Singh UK, Mehrotra RM. Role of rubella in congenital malformations in India. J Hyg (Lond). 1976;76:33-40.
23. Mahalakshmi B, Therese KL, Devipriya U, Pushplatha V, Margarita S, Madhavan HN. Infectious aetiology of congenital cataract based on TORCHES screening in a tertiary eye hospital in Chennai, Tamil Nadu, India. Indian J Med Res. 2010;131:559-64.
24. Khandekar R, Sudhan A, Jain BK, Shrivastav K, Sachan R. Pediatric cataract and surgery outcomes in Central India: A hospital based study. Indian J Med Sci. 2007;61:15-22.
25. Johar SR, Savalia NK, Vasavada AR, Gupta PD. Epidemiology based etiological study of pediatric cataract in western India. Indian J Med Sci. 2004;58:115-21.
26. Malathi J, Therese KL, Madhavan HN. The association of rubella virus in congenital cataract-A hospital-based study in India. J Clin Virol. 2001;23:25-9.
27. Madhavan HN. Laboratory investigations on viral and Chlamydia trachomatis infections of the eye: Sankara Nethralaya experiences. Indian J Ophthalmol. 1999;47:241-6.
28. Eckstein M, Vijayalakshmi P, Killedar M, Gilbert C, Foster A. Aetiology of childhood cataract in south India. Br J Ophthalmol. 1996;80:628-32.
29. Eckstein MB, Brown DW, Foster A, Richards AF, Gilbert CE, Vijayalakshmi P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ. 1996;312:161.
30. Angra SK. Etiology and management of congenital cataract. Indian J Pediatr. 1987;54:673-7.
31. Angra SK, Morgan M. Rubella cataract. Indian J Ophthalmol. 1982;30:445-8.
32. Rout N, Parveen S, Chattopadhyay D, Kishore MT. Risk factors of hearing impairment in Indian children: A retrospective case-file study. Int J Rehabil Res. 2008;31:293-6.
33. Reddy MVV, Bindu HL, Reddy PP, Rani UP. Role of intrauterine rubella infection in the causation of congenital deafness. Indian Journal of Human Genetics. 2006;12:140-3.
34. Arora S, Kochhar LK. Incidence evaluation of SNHL in neonates. Indian Journal of Otolaryngology and Head and Neck Surgery. 2003;55:246-50.
35. Gray RF. Causes of deafness in schools for the deaf in Madras. Int J Pediatr Otorhinolaryngol. 1989;18:97-106.
36. Gandhoke I, Aggarwal R, Lal S, Khare S. Seroprevalence and incidence of rubella in and around Delhi (1988-2002). Indian J Med Microbiol. 2005;23(3):164-7.
37. Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, et al. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. J Infect Dev Ctries. 2011;5:74-81.
38. Sharma H, Chowdhari S, Raina TR, Bhardwaj S, Namjoshi G, Parekh S. Serosurveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls. Indian J Community Med. 2010;35:134-7.
39. Ramamurty N, Murugan S, Raja D, Elango V, Mohana, Dhanagaran D. Serosurvey of rubella in five blocks of Tamil Nadu. Indian J Med Res. 2006;123:51-4.
40. Singla N, Jindal N, Aggarwal A. The seroepidemiology of rubella in Amritsar (Punjab). Indian J Med Microbiol. 2004;22:61-3.
41. Yadav S, Wadhwa V, Chakarvarti A. Prevalence of rubella antibody in schoolgoing girls. Indian Pediatr. 2001;38:280-3.
42. Yadav S, Gupta S, Kumari S. Seroprevalence of rubella in women of reproductive age. Indian J Pathol Microbiol. 1995;38:139-42.
43. Bhaskaram P, Ramalakshmi BA, Raju LA, Raman L. Need for protection against rubella in India. Indian J Pediatr. 1991;58:811-4.
44. Pal SR, Chitkara NL, Broor S, Murthy JG, Choudhury S, Devi PK. Serological investigation of rubella virus infection in and around Chandigarh-A preliminary communication. Indian J Med Res. 1974;62:240-5.
45. Mathur A, Chaturvedi UC, Mehrotra RM. Serological study for the prevalence of rubella at Lucknow. Indian J Med Res. 1974;62:307-12.
46. Chakraborty MS, Mukherjee MK, Sarkar JK. Rubella antibody profile in women of child-bearing age in Calcutta area. Indian J Med Res. 1973;61:340-3.
47. Chakraborty MS, Mukherjee MK, Sarkar JK. Incidence of Rubella antibody in a selected group of women of Calcutta. Bull Calcutta Sch Trop Med. 1971;19:89-90.
48. Seth P, Balaya S, Mohapatra LN. Sero-epidemiological study of rubella infection in female subjects of Delhi and its surrounding villages. Indian J Med Res. 1971;59:190-4.
49. Rajasundari TA, Chandrasekar K, Vijayalakshmi P, Muthukkaruppan V. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital. Indian J Med Res. 2006;124:553-8.
50. Rustgi R, Deka D, Sarman S. Rubella serology in Indian adolescent girls and its relation to socio-economic status. Journal of Obstetrics and Gynaecology of India. 2005;55:167-9.
51. Vijayalakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, et al. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India. Bull World Health Organ. 2004;82:259-64.
52. Padmaja M, Radhakrishna PM, Varghese SJ. Seroprevalence of immunity to rubella in pregnant women. Natl Med J India. 2010;23:248-9.
53. Gupta E, Dar L, Broor S. Seroprevalence of rubella in pregnant women in Delhi, India. Indian J Med Res. 2006;123:833-5.
54. Deka D, Rustgi R, Singh S, Roy KK, Malhotra N. Diagnosis of acute rubella infection during pregnancy. Journal of Obstetrics and Gynaecology of India. 2006;56:44-6.
55. Thapliyal N, Shukla PK, Kumar B, Upadhyay S, Jain G. TORCH infection in women with bad obstetric history-A pilot study in Kumaon region. Indian J Pathol Microbiol. 2005;48:551-3.
56. Turbadkar D, Mathur M, Rele M. Seroprevalence of torch infection in bad obstetric history. Indian J Med Microbiol. 2003;21:108-10.
57. Khare S, Banerjee K, Padubidri V, Rai A, Kumari S, Kumari S. Lowered immunity status of rubella virus infection in pregnant women. J Commun Dis. 1987;19:391-5.
58. Black FL, Berman LL, Borgoño JM, Capper RA, Carvalho AA, Collins C, et al. Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. Am J Epidemiol. 1986;124:442-52.
59. Shanmugam J, Raveendranath M, Nair VR. Seroprevalence of rubella and cytomegalovirus (CMV) infection in pregnant women from Kerala State. J Indian Assoc Commun Dis. 1982;5:58-63.
60. Mathur A, Tripathi R, Chaturvedi UC, Mehra P. Congenital rubella following inapparent rubella infection. Indian J Med Res. 1982;75:469-73.
61. Chakravarty MS, Gupta B, Das BC, Mukherjee MK, Mitra AC, Sarkar JK. Seroepidemiological study of rubella in Calcutta. Indian J Med Res. 1976;64:87-92.
62. Seth P, Balaya S, Mohapatra LN. Rubella antibody in pregnant women. Indian J Pathol Bacteriol. 1972;15:23-6.
63. Rajasundari TA, Chandrasekar K, Vijayalakshmi P, Muthukkaruppan V. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital. Indian J Med Res. 2006;124:553-8.
64. Gomber S, Arora SK, Das S, Ramachandran VG. Immune response to second dose of MMR vaccine in Indian children. Indian J Med Res. 2011;134:302-6.
65. Raut SK, Kulkarni PS, Phadke MA, Jadhav SS, Kapre SV, Dhere RM, et al. Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India. Clin Vaccine Immunol. 2007;14:1370-1.
66. Yadav S, Thukral R, Chakarvarti A. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Indian J Med Res. 2003;118:183-6.
67. Bhargava I, Chhaparwal BC, Phadke MA, Irani SF, Chhaparwal D, Dhorje S, Maheshwari CP. Immunogenicity and reactogenicity of indigenously produced MMR vaccine. Indian Pediatr. 1995;32:983-8.
68. Singh R, John TJ, Cherian T, Raghupathy P. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age. Indian J Med Res. 1994;100:155-9.
69. Government of India and Ministry of Health and Family Welfare. 2009 Coverage evaluation survey National factsheet. Available from: http://www.unicef.org/india/National-Fact-Sheet-CES-2009.pdf. Accessed on February 12, 2012.
70. Chhabra P, Nair P, Gupta A, Sandhir M, Kannan AT. Immunization in urbanized villages of Delhi. Indian J Pediatr. 2007;74:131-4.
71. Puri S, Bhatia V, Singh A, Swami HM, Kaur A. Uptake of newer vaccines in Chandigarh. Indian J Pediatr. 2007;74:47-50.
72. Dalal A, Silveira MP. Immunization status of children in Goa. Indian Pediatr. 2005;42:401-2.
73. International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3), 2005-06: India. Mumbai: IIPS; 2008.
74. Kumar M, Agarwal T, Khokhar S, Kumar M, Kaur P, Roy TS, et al. Mutation screening and genotype phenotype correlation of á-crystallin, ã-crystallin and GJA8 gene in congenital cataract. Mol Vis. 2011;17:693-707.
75. Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol. 1998;46:169-72.
76. Saxena SG, Gupta P. National health programs in India. In: Gupta P (Ed). Textbook of Preventive and Social Medicine. 3rd edition. Delhi: CBS Publishers; 2010. p.772.
77. Vijayalakshmi P, Srivastava KK, Poornima B, Nirmalan P. Visual outcome of cataract surgery in children with congenital rubella syndrome. J AAPOS. 2003;7:91-5.
78. World Health Organization. Surveillance guidelines for measles and congenital rubella infection in the WHO European Region. Copenhagen: World Health Organization; 2003.
79. Government of National Capital Territory of Delhi. Immunization services in Delhi. Available from: http://www.delhi.gov.in/wps/wcm/connect/DoIT-Health/ health/home/family+welfare/mch/immunization+services. Accessed on February 15, 2012.
80. Sanklecha M. Measles vaccine versus MMR. Indian Pediatr. 2011;48:742-3.
81. Goa Children's Act 2003. Available from: http://www.stoptrafficking.in/ UserDocs/Goa-Childrens-Act-2003.pdf. Accessed on March 6, 2012.
82. Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec. 2007;82:51-60.
83. Rubella vaccines. WHO position paper. Wkly Epidemiol Rec. 2000;75:161-9.
84. Meissner HC, Reef SE, Cochi S. Elimination of rubella from the United States: A milestone on the road to global elimination. Pediatrics. 2006;117:933-5.
85. Castillo-Solórzano C, Reef SE, Morice A, Andrus JK, Ruiz Matus C, Tambini G, et al. Guidelines for the documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas. J Infect Dis. 2011;204 Suppl 2:S683-9.
86. Zimmerman LA, Muscat M, Jankovic D, Goel A, Bang H, Khetsuriani N, et al. Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region. J Infect Dis. 2011;204 Suppl 1:S381-8.
87. Muscat M, Zimmerman L, Bacci S, Bang H, Glismann S, Mølbak K, et al. Toward rubella elimination in Europe: An epidemiological assessment. Vaccine. 2012;30:1999-2007.
88. DrugsUpdate.com. Available from: http://www.drugs update.com/brand/ showavailablebrands/560. Accessed on March 6, 2012.